Streetwise Life Sciences Tools & Diagnostics Sponsors
Select a name to see a detailed description, expert analysis and contact information.
|"Well financed, with over two years of expenses in the bank, VGZ is a strong buy."|
|"I am expecting some significant news from GYA."|
|"TXR is in a really interesting position to do well in 2018."|
|"VIVE intends to expand its CMRF platform into a new market."|
|"KDX's final Zeus results returned multiple high-grade Au-Ag intervals."|